Cullen/Frost Bankers, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Cullen/Frost Bankers, Inc.

$7.83 Billion
Q2 2025

A detailed history of Cullen/Frost Bankers, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 6,423 shares of REGN stock, worth $3.51 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

6,423

Previous 6,868 6.48%

Holding current value

$3.51 Million

Previous $4.36 Million 22.57%

% of portfolio

0.04%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	SELL	$483.07 - $625.6 $214,966 - $278,392	-445 Reduced 6.48%	6,423 $3.37 Million
Q1 2025 May 02, 2025	BUY	$634.14 - $744.83 $355,752 - $417,849	561 Added 8.89%	6,868 $4.36 Million
Q4 2024 Feb 06, 2025	BUY	$701.85 - $1046.91 $4.1 Million - $6.11 Million	5,838 Added 1244.78%	6,307 $4.49 Million
Q3 2024 Nov 06, 2024	BUY	$1024.09 - $1201.76 $43,011 - $50,473	42 Added 9.84%	469 $493,000
Q2 2024 Aug 05, 2024	BUY	$883.2 - $1071.19 $89,203 - $108,190	101 Added 30.98%	427 $448,000
Q1 2024 May 10, 2024	BUY	$902.69 - $993.35 $8,124 - $8,940	9 Added 2.84%	326 $313,000
Q4 2023 Feb 06, 2024	SELL	$775.18 - $881.7 $15,503 - $17,634	-20 Reduced 5.93%	317 $278,000
Q3 2023 Nov 02, 2023	BUY	$692.45 - $844.37 $34,622 - $42,218	50 Added 17.42%	337 $277,000
Q2 2023 Aug 04, 2023	SELL	$700.03 - $830.35 $28,001 - $33,214	-40 Reduced 12.23%	287 $206,000
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $21,882 - $23,758	-31 Reduced 8.66%	327 $235,000
Q3 2022 Nov 07, 2022	BUY	$573.97 - $724.32 $35,586 - $44,907	62 Added 20.95%	358 $247,000
Q2 2022 Aug 05, 2022	SELL	$548.35 - $738.84 $2,193 - $2,955	-4 Reduced 1.33%	296 $175,000
Q4 2021 Feb 07, 2022	BUY	$543.48 - $670.97 $2,173 - $2,683	4 Added 1.35%	300 $189,000
Q3 2021 Nov 04, 2021	BUY	$574.03 - $680.96 $169,912 - $201,564	296 New	296 $179,000
Q1 2021 May 05, 2021	SELL	$446.73 - $548.2 $67,009 - $82,230	-150 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$478.3 - $607.98 $55,961 - $71,133	-117 Reduced 43.82%	150 $72,000
Q3 2020 Nov 05, 2020	BUY	$544.75 - $658.21 $9,260 - $11,189	17 Added 6.8%	267 $149,000
Q2 2020 Aug 05, 2020	BUY	$493.32 - $643.92 $73,998 - $96,588	150 Added 150.0%	250 $156,000
Q1 2019 Apr 30, 2019	BUY	$372.08 - $439.57 $37,208 - $43,957	100 New	100 $41,000

Others Institutions Holding REGN

# of Institutions

1,409

Shares Held

84.9M

Call Options Held

1.39M

Put Options Held

1.42M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $58.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.

Account

Cullen/Frost Bankers, Inc. Regeneron Pharmaceuticals, Inc. Transaction History